-
Mashup Score: 39
Hypertrophic cardiomyopathy (HCM) is one of the most common inherited cardiovascular diseases, with a prevalence between 1:200 and 1:500, affecting more than 20 million people worldwide [1]. Although the majority (∼75%) of HCM patients have normal life expectancy without limiting symptoms, the natural history of the disease includes ominous events such as atrial fibrillation and stroke, infective endocarditis, heart failure (HF) to the worst scenario represented by sudden cardiac death (SCD). HF can develop over time mainly through three different phenotypes: left ventricular (LV) obstruction (obstructive HCM), non-obstructive HCM with a normal or preserved ejection fraction (LVEF), “end-stage” HCM or hypokinetic-dilated evolution (ES-HCM) [1].The major determinants of the most ominous outcomes, namely, all-cause death, SCD, hospitalization for HF, and HF progression, have been largely researched and studied over time and only partially identified and characterized. To date, the role o
Source: karger.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 13Aetiology and clinical manifestations of patients with non‐dilated left ventricular cardiomyopathy - 2 month(s) ago
Click on the article title to read more.
Source: onlinelibrary.wiley.comCategories: General Medicine News, CardiologistsTweet-
🔥 Aetiology & Clinical manifestations of #NDLVC 🍀 Genetic a prevalent cause 🔬 Myocarditis can uncover a genetic #CMP 🫀 #NDLVC a starting disease phenotype #HFUA https://t.co/lBtF2d1NQD @radcliffeCARDIO @Cardioinfo_it @gbiondizoccai @m4ggiesimpson @DrMarthaGulati https://t.co/ikjGQVDwHa
-
-
Mashup Score: 16Heart failure risk assessment in patients with hypertrophic cardiomyopathy based on the H2FPEF score - 2 month(s) ago
The H2FPEF score in hypertrophic cardiomyopathy. CI, confidence interval; HCM, hypertrophic cardiomyopathy; LV, left ventricular; sPAP, systolic pulmonary artery pressure.
Source: onlinelibrary.wiley.comCategories: General Medicine News, CardiologistsTweet-
🔥 #HF risk assessment in #HCM based on the #H2FPEF score Risk prediction in both #HOCM & #HNOCM #HCM a cause of #HFpEF 🫀 #HFUA @ESC_Journals @EJHFEiC @AmrAbdin10 @HanCardiomd @IacopoOlivotto @glimongelli @MicheleEmdin @gcfmd @JJheart_doc https://t.co/qqbukOXRNI https://t.co/4JtsmAvpql https://t.co/47yF6xjbYZ
-
-
Mashup Score: 68Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction | NEJM - 2 month(s) ago
Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure and m…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
🔥❤️🔥 #FINEARTS_HF. #FineHearts_HF #Finerenone confirmed a 16% RRR of #CV ☠️ & Total #HHF 🏥 A 2nd pillar for #HFmrEF & #HFpEF has just been built 🏛️ #HFUA @EJHFEiC @NEJM @gcfmd @JJheart_doc @AndrewJSauer @BiykemB @MicheleEmdin @iamritu @pabeda1 https://t.co/Rd5af1gdX7 https://t.co/v6Hw0ya5Zh
-
-
Mashup Score: 69Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction | NEJM - 2 month(s) ago
Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure and m…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
🔥❤️🔥 #FINEARTS_HF. #FineHearts_HF #Finerenone confirmed a 16% RRR of #CV ☠️ & Total #HHF 🏥 A 2nd pillar for #HFmrEF & #HFpEF has just been built 🏛️ #HFUA @EJHFEiC @NEJM @gcfmd @JJheart_doc @AndrewJSauer @BiykemB @MicheleEmdin @iamritu @pabeda1 https://t.co/Rd5af1gdX7 https://t.co/v6Hw0ya5Zh
-
-
Mashup Score: 37Impact of heart failure hospitalizations on clinical outcomes after mitral transcatheter edge‐to‐edge repair: Results from the EXPAND study - 2 month(s) ago
In the EXPAND study, subjects with prior HFH had an increased incidence of all-cause mortality at 1 year. Associations with 1-year HFH after mitral transcatheter edge-to-edge repair included residual…
Source: onlinelibrary.wiley.comCategories: General Medicine News, CardiologistsTweet-
🔥 #EXPAND : A real life study that confirms that the major driver of benefits of #MitraClip in #FMR & #HFrEF 👉⬇️ #HHF 🏥 & ⬆️ of #QoL See Tweet2👇 #HFUA @ESC_Journals @EJHFEiC @AmrAbdin10 @HanCardiomd @gcfmd @MicheleEmdin @JJheart_doc @iamritu https://t.co/2n4395ve4V https://t.co/pqfAMFIfcn https://t.co/m1344Y0hS6
-
-
Mashup Score: 68Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction | NEJM - 2 month(s) ago
Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure and m…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
🔥❤️🔥 #FINEARTS_HF. #FineHearts_HF #Finerenone confirmed a 16% RRR of #CV ☠️ & Total #HHF 🏥 A 2nd pillar for #HFmrEF & #HFpEF has just been built 🏛️ #HFUA @EJHFEiC @NEJM @gcfmd @JJheart_doc @AndrewJSauer @BiykemB @MicheleEmdin @iamritu @pabeda1 https://t.co/Rd5af1gdX7 https://t.co/v6Hw0ya5Zh
-
-
Mashup Score: 68Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction | NEJM - 2 month(s) ago
Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure and m…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
🔥❤️🔥 #FINEARTS_HF. #FineHearts_HF #Finerenone confirmed a 16% RRR of #CV ☠️ & Total #HHF 🏥 A 2nd pillar for #HFmrEF & #HFpEF has just been built 🏛️ #HFUA @EJHFEiC @NEJM @gcfmd @JJheart_doc @AndrewJSauer @BiykemB @MicheleEmdin @iamritu @pabeda1 https://t.co/Rd5af1gdX7 https://t.co/v6Hw0ya5Zh
-
-
Mashup Score: 67Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction | NEJM - 2 month(s) ago
Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure and m…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
🔥❤️🔥 #FINEARTS_HF. #FineHearts_HF #Finerenone confirmed a 16% RRR of #CV ☠️ & Total #HHF 🏥 A 2nd pillar for #HFmrEF & #HFpEF has just been built 🏛️ #HFUA @EJHFEiC @NEJM @gcfmd @JJheart_doc @AndrewJSauer @BiykemB @MicheleEmdin @iamritu @pabeda1 https://t.co/Rd5af1gdX7 https://t.co/v6Hw0ya5Zh
-
-
Mashup Score: 66Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction | NEJM - 2 month(s) ago
Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure and m…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
🔥❤️🔥 #FINEARTS_HF. #FineHearts_HF #Finerenone confirmed a 16% RRR of #CV ☠️ & Total #HHF 🏥 A 2nd pillar for #HFmrEF & #HFpEF has just been built 🏛️ #HFUA @EJHFEiC @NEJM @gcfmd @JJheart_doc @AndrewJSauer @BiykemB @MicheleEmdin @iamritu @pabeda1 https://t.co/Rd5af1gdX7 https://t.co/v6Hw0ya5Zh
-
🔥 Our new editorial on #Cardiology 🍀 “The Role of Multiple Mutations in #HCM - A New Universe to Discover: Proof of Guiltiness of the Genetic Burden in Worsening Hypertrophic Cardiomyopathy Natural History @CardioKarger With @RFE_Pedretti #OGermanova https://t.co/ZiBvLuUsLj https://t.co/AQU60PLLCS